Tracking the evolution of circulating exosomal‐PD‐L1 to monitor melanoma patients-Reference-Cited by-同舟云学术

Tracking the evolution of circulating exosomal‐PD‐L1 to monitor melanoma patients

Published:2020-01-07 Issue:1 Volume:9 Page:1710899
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:Journal of Extracellular Vesicles

Author:

Cordonnier Marine¹²,Nardin Charlée³⁴,Chanteloup Gaëtan¹²,Derangere Valentin¹⁵,Algros Marie‐Paule⁴,Arnould Laurent⁵,Garrido Carmen¹²⁵,Aubin François³⁴,Gobbo Jessica¹²⁵⁶

Affiliation:

1. INSERM 1231, Label “Ligue National contre le Cancer“ and Label d'Excellence LipSTICDijonFrance

2. Faculty of MedicineUniversity of Burgundy‐Franche‐ComtéDijonFrance

3. University of Burgundy‐Franche‐ComtéBesançonFrance

4. Department of DermatologyUniversity Hospital CenterBesançonFrance

5. Department of Medical OncologyCenter Georges‐François LeclercDijonFrance

6. Inserm, CIC1432, Module plurithématique, U2PDijonFrance

Funder

Conseil régional de Bourgogne-Franche-Comté

Fondation pour la Recherche Médicale

Institut National Du Cancer

Ligue Contre le Cancer

Agence Nationale de la Recherche

Centre Georges-Francois Leclerc

French National Research Agency (ANR) under the program “Investissements d’Avenir

Fondation Silab Jean Paufique

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1080/20013078.2019.1710899

Reference32 articles.

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

2. Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

3. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

4. Melanoma subtypes demonstrate distinct PD-L1 expression profiles

5. PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of exosomes in immunotherapy for solid cancers;Cell Death & Disease;2024-02-01

2. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy;Acta Pharmaceutica Sinica B;2024-02

3. Biological, pathological, and multifaceted therapeutic functions of exosomes to target cancer;Oncology Research;2024

4. Exosome subpopulations: The isolation and the functions in diseases;Gene;2024-01

5. Promising and Minimally Invasive Biomarkers: Targeting Melanoma;Cells;2023-12-20